Proton Therapy Center Leads Clinical Trial of FLASH Therapy
Post Date: October 27, 2021 | Publish Date:
The first human clinical trial of FLASH therapy, a new method of proton therapy for cancer, reached an important milestone in October 2021.
Enrollment is complete for FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases), according to a news release from Varian, the manufacturer of the system that delivers the therapy.
The FAST-01 trial is being led by John Breneman, MD, principal investigator, and Medical Director of the Cincinnati Children’s/UC Health Proton Therapy Center.
The $120 million Proton Therapy Center, located at Cincinnati Children’s Liberty Township campus, marked its five-year anniversary in October.